The human immune system is a powerful defense network that protects us from countless invading microbes every day. Yet, without precise regulation, this same system could mistakenly attack the body’s own tissues. The 2025 Nobel Prize in Physiology or Medicine was awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi for uncovering how peripheral immune tolerance prevents such self-destruction. Their groundbreaking discoveries have revolutionized immunology and laid the foundation for new therapies against cancer, autoimmune diseases, and transplant rejection.
The Immune System: A Sophisticated Guardian
Our immune system constantly identifies and eliminates harmful pathogens while distinguishing them from the body’s own cells — a critical function for survival. For decades, scientists believed this self-protection relied mainly on central immune tolerance, where self-reactive T cells are destroyed during their development in the thymus. However, the work of Brunkow, Ramsdell, and Sakaguchi revealed a more intricate second layer of control known as peripheral immune tolerance, which ensures immune balance even after T cells leave the thymus.
T Cells: Frontline Soldiers with a Double-Edged Sword
T cells are at the heart of immune defense. Helper T cells coordinate immune responses by signaling other immune cells, while killer T cells eliminate infected or cancerous cells. Each T cell carries a unique receptor, enabling the immune system to recognize a vast range of invaders. Yet, this diversity has a downside — some T cells mistakenly target the body’s own tissues. While many of these are eliminated in the thymus (central tolerance), some slip through, creating the need for peripheral mechanisms to keep them in check.
Shimon Sakaguchi and the Discovery of Regulatory T Cells
In the early 1980s, Shimon Sakaguchi at the Aichi Cancer Center in Japan explored why mice lacking a thymus developed severe autoimmune diseases. His pioneering experiments uncovered a distinct group of T cells capable of suppressing excessive immune activity. After more than a decade of work, Sakaguchi identified these cells as regulatory T cells (Tregs). In 1995, he demonstrated that they express two key surface proteins — CD4 and CD25 — and act as the immune system’s “security guards,” preventing destructive autoimmune responses.
The Mystery of the Scurfy Mice
Around the same time, researchers in the United States were studying a peculiar mouse strain discovered in the 1940s. These “scurfy” mice exhibited scaly skin, enlarged spleens, and fatal immune system malfunctions — clear signs of autoimmune attack. In the 1990s, Mary Brunkow and Fred Ramsdell at Celltech Chiroscience began investigating this mysterious condition. Their goal: to uncover the genetic cause behind the immune system’s self-targeting behavior.
Cracking the Genetic Code: The FOXP3 Gene
Through painstaking DNA mapping, Brunkow and Ramsdell pinpointed the culprit — a defective gene on the X chromosome they named Foxp3. This gene belongs to the forkhead box (FOX) family, known for regulating gene expression and cell development.
Their landmark discovery linked mutations in the human equivalent of FOXP3 to a rare autoimmune disorder called IPEX (Immune dysregulation, Polyendocrinopathy, Enteropathy, X-linked syndrome). In 2001, they published their findings in Nature Genetics, showing that FOXP3 mutations cause both scurfy disease in mice and IPEX in humans.
Connecting FOXP3 to Regulatory T Cells
The final piece of the puzzle came in 2003, when Sakaguchi and other researchers demonstrated that FOXP3 is essential for regulatory T cell development. These cells are the cornerstone of peripheral immune tolerance, preventing other T cells from attacking the body’s own tissues. Beyond suppressing autoimmunity, Tregs play a crucial role in calming the immune system after infections, ensuring immune activity returns to normal and doesn’t spiral out of control.
From Discovery to Therapy: Transforming Modern Medicine
The discoveries of regulatory T cells and FOXP3 have fueled a new generation of therapeutic strategies:
*Cancer Therapy: Scientists are exploring ways to block regulatory T cells that protect tumors from immune attacks, enhancing the effectiveness of immunotherapies.
*Autoimmune Diseases: Treatments aim to boost Treg production using interleukin-2 (IL-2) to restore immune balance.
*Transplant Medicine: Researchers are testing IL-2 therapy and Treg-based approaches to prevent organ rejection and promote long-term transplant success.
Some experimental treatments even involve extracting and expanding regulatory T cells in the lab before reintroducing them into patients. These modified Tregs can be directed to specific organs such as a transplanted kidney or liver — to shield them from immune damage.</p>
A Lasting Impact on Human Health
The pioneering work of Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi has fundamentally reshaped our understanding of immune regulation. They uncovered how peripheral immune tolerance safeguards the body. This discovery opened the door to transformative therapies for cancer, autoimmune diseases, and transplant medicine. Their discoveries underscore how basic scientific research can translate into profound medical advances — changing not only the field of immunology but also the future of patient care.
